Please assess the completion status of the following clinical trial:

Trial Title: Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women\>18 years,~* during first stage of normal labor,~* at 36 to 42 weeks,~* with epidural analgesia and informed signed consent~Exclusion Criteria:~* Cesarean section delivery,~* clotting disorders,~* prostaglandin allergy,~* absent consent.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Misoprostol (Type: EXPERIMENTAL): 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400µg) following cord clamp
- PLACEBO (Type: PLACEBO_COMPARATOR): 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp.

Based on this trial design, predict the completion outcome and termination type (if applicable).